Drawing for CENTOPHARMA

USPTO serial 88546263

CENTOPHARMA

Reviewed by CopyMark Law Group

Reg. 6127982Status 700Renewal
Filing date
Status date
Registration date
Aug 18, 2020
Examiner
ALAO, OREOLUWA
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CENTOPHARMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,295*

Plus Government fees of $2,125

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Angela P. Doughty

Angela P. Doughty WARD AND SMITH, P.A.751 CORPORATE CENTER DRIVEPOST OFFICE BOX 33009RALEIGH, NC 27636-3009

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for hereditary diseases, metabolic diseases, oncological diseases, and complex multigenic diseases and veterinary preparations for hereditary diseases, metabolic diseases, oncological diseases, and complex multigenic diseases; diagnostic preparations for medical purposes; chemical preparations for analyses in laboratories, for medical and veterinary purposes, namely for detecting genetic predispositions; chemical preparations for analyses in laboratories, for medical or veterinary purposes, namely, nucleic acid and chemical reagents; biological preparations for medical purposes for the treatment of hereditary diseases, metabolic diseases, oncological diseases and complex multigenic diseases; Cultures of microorganisms for medical or veterinary useACTIVE—
009Scientific, surveying, weighing, measuring and checking apparatus and instruments, namely, fluorometers, spectrophotometers, real-time polymerase chain reaction (PCR) devices for gene expression and genotyping, DNA analyzers, DNA fragmentation and capture devices, thermal cycler, and thermal blocks for incubations all to determine the structure, composition or sequence of DNA on multiple genes or on the whole genomic coding region or the whole genome, to determine structure, composition or sequence of RNA and for biochemical measurements of biomarkers; apparatus and instruments for scientific research in laboratories, namely, scientific devices to determine DNA or RNA sequence, alterations, rearrangements, copy number variations, and deletions; apparatus and instruments for scientific research in laboratories, namely, devices to determine biochemical markers, namely, fluorometers, spectrophotometers, real-time polymerase chain reaction (PCR) devices for gene expression and genotyping, DNA analyzers, and DNA fragmentation and capture devices all for scientific purposes; apparatus and instruments for scientific research in laboratories, namely, devices to prepare respective biological samples for acquiring measurements, namely, thermal cyclers, thermal blocks, magnetic beads, pipetting tips, microcentrifuge tubes, and 96-well microplates; pre-recorded compact discs, DVDs, and other digital recording media, namely, downloadable audio and video digital recordings, and digital video media, all featuring clinical phenotypic, genetic molecular and demographic information; computers; downloadable computer software for database management and for managing, analyzing, interpreting and storing the data obtained from laboratory instrumentsACTIVE—
035Collating and systematic ordering of data in a computer database, namely, database management and computerized file management; Computerized file management; Industrial analysis services, namely, industrial management consultation including cost/yield analyses and marketing research servicesACTIVE—
042Scientific and technological services namely, genetic and biochemical analytical testing for scientific research purposes and new product research and design relating thereto; Industrial analysis services and provision of research services in the field of genetics and in the field of pharmaceutical development; Scientific research for medical purposes in the field of hereditary diseases, oncology, and complex genetics related diseases; Design and development of computer hardware and computer software; Services of a medical laboratory; medical laboratory services for the analysis of samples taken from patients; Provision of information in the field of pharmacology; providing online non-downloadable computer software for database management and for managing, analyzing, interpreting and storing the data obtained from laboratory instrumentsACTIVE—
044Medical and veterinary services, in particular, medical analysis in connection with the treatment of individuals; Providing information in the fields of medicine and veterinary medicine; Health center services, namely, genetic centers providing medical diagnostic, preventive and curative therapy services for genetic disorders, cancer treatment centers, rare disease treatment centers, children's hospitals and women's hospital; Medical clinic services; medical clinic services, namely, medical testing of blood, biological tissue, saliva, urine and hair follicles; gene therapy services in the field of oncology, infertility, prenatal diagnostics, carrier testing, and genetically inherited diseasesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 18, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Nov 11, 2020ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Aug 18, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 2, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 2, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 13, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 28, 2020ALIEASSIGNED TO LIE—
Apr 22, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 21, 2020XAECEXAMINER'S AMENDMENT ENTERED—
Apr 21, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 21, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 21, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 11, 2020GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Feb 11, 2020GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 11, 2020CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 17, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 17, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 17, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 25, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 25, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 25, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 18, 2019DOCKASSIGNED TO EXAMINER—
Aug 8, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 1, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance